Vulvar Cancer
Showing 1 - 25 of 78
Vulvar Cancer Trial in United States (ICG guided sentinel lymph node biopsy)
Recruiting
- Vulvar Cancer
- ICG guided sentinel lymph node biopsy
-
Basking Ridge, New Jersey
- +6 more
Nov 7, 2023
Vulvar Cancer Trial (ICG alone)
Not yet recruiting
- Vulvar Cancer
- ICG alone
- (no location specified)
Sep 8, 2023
Vulvar Cancer, Sentinel Lymph Node Trial in Copenhagen
Recruiting
- Vulvar Cancer
- Sentinel Lymph Node
-
Copenhagen, DenmarkCopenhagen University Hospital
Sep 1, 2023
Ovarian Tumors, Endometrial Tumors, Uterine Cervical Tumors Trial (Dostarlimab, Bevacizumab, Doxorubicin)
Not yet recruiting
- Ovarian Neoplasms
- +5 more
- Dostarlimab
- +4 more
- (no location specified)
Sep 3, 2023
Vulvar Cancer Individualized Scoring System (VCISS)
Not yet recruiting
- Vulvar Cancer
- Machine learning-based prediction model
-
Alexandria, Egypt
- +1 more
Aug 22, 2023
Gynecologic Tumor, Brachytherapy, Therapeutic Touch Trial in Salt Lake City (Reiki therapy)
Not yet recruiting
- Gynecologic Neoplasm
- +6 more
- Reiki therapy
-
Salt Lake City, UtahHuntsman Cancer Institute
Aug 9, 2023
Cancer, Breast, Cancer Colorectal, Cancer, Ovarian Trial in Birmingham (Proactive Cost of Care (P-COC) intervention, Usual Care)
Recruiting
- Cancer, Breast
- +5 more
- Proactive Cost of Care (P-COC) intervention
- Usual Care
-
Birmingham, AlabamaO'Neal Comprehensive Cancer Center
Jun 30, 2023
Vulvar Cancer Trial in Ljubljana (Electrochemo with bleomycin or cisplatin)
Recruiting
- Vulvar Cancer
- Electrochemotherapy with bleomycin or cisplatin
-
Ljubljana, SloveniaInstitute of Oncology Ljubljana
Jun 14, 2023
Immunotherapy-related CRP Kinetics in Metastatic Gynecological
Recruiting
- Gynecological Malignancies
- +4 more
-
Tuebingen, GermanyDepartment of Women's Health
Jun 13, 2023
Vulvar Cancer Trial in Beijing (optical surface monitoring system)
Completed
- Vulvar Cancer
- optical surface monitoring system
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 2, 2023
Ovary Cancer, Endometrial Cancer, Uterine Cancer Trial in Chicago (Fit4Treatment)
Not yet recruiting
- Ovary Cancer
- +6 more
- Fit4Treatment
-
Chicago, IllinoisNorthwestern University
Feb 21, 2023
Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)
Recruiting
- Advanced Cancer
- +24 more
- pembrolizumab
-
Los Angeles, California
- +21 more
Jan 18, 2023
HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T
Not yet recruiting
- HPV-Associated Cervical Carcinoma
- +16 more
- Conditioning, E7 TCR-T cells, and aldesleukin
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 17, 2023
Squamous Cell Lung Cancer, Vulvar Cancer, Penile Cancer Trial in France (pembrolizumab; vorinostat)
Active, not recruiting
- Squamous Cell Lung Cancer
- +5 more
- pembrolizumab; vorinostat
-
Angers, France
- +13 more
Jan 4, 2023
Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)
Recruiting
- Adenocarcinoma
- +75 more
- Biomarker Testing (L)
- +2 more
-
Idaho Falls, Idaho
- +1 more
Oct 18, 2022
Vulvar Cancer Trial in Vancouver (Re-excision)
Not yet recruiting
- Vulvar Cancer
- Re-excision
-
Vancouver, British Columbia, CanadaBC Cancer - Vancouver Centre
Oct 8, 2022
Gynecologic Cancer, Uterus Cancer, Ovary Cancer Trial in Belfast (Mindfulness and exercise, Mindfulness)
Recruiting
- Gynecologic Cancer
- +5 more
- Mindfulness and exercise
- Mindfulness
-
Belfast, Antrim, United KingdomUlster University
Sep 29, 2022
Glioblastoma, Esophageal Cancer, Radiotherapy Trial in Boston (MRI IMAGING)
Recruiting
- Glioblastoma
- +7 more
- MRI IMAGING
-
Boston, Massachusetts
- +1 more
Aug 8, 2022
Vulvar Cancer Trial in Bologna (Carboplatin, Bleomycin)
Recruiting
- Vulvar Cancer
-
Bologna, Bo, ItalyIRCCS- Azienda Ospedaliera-Universitaria di Bologna
May 25, 2022
Lymphedema After Sentinel Lymph Node Biopsy in People With
Recruiting
- Cervical Cancer
- Vulvar Cancer
- Questionnaires
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 20, 2022
HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Guangxi (Experimental: Experimental: 9-valent Human Papillomavirus
Completed
- HPV Infections
- +14 more
- Experimental: Experimental: 9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)
- Active Comparator: GARDASIL ®9
-
Guangxi, ChinaGuangxi Zhuang Autonomous Region Center for Disease Control and
May 9, 2022
HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Hangzhou (9-valent HPV vaccine)
Recruiting
- HPV Infections
- +14 more
- 9-valent HPV vaccine
-
Hangzhou, ChinaHuakun Lv
Feb 23, 2022
Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Yangchun (4-valent HPV Vaccine, 9-valent HPV Vaccine, GARDASIL®)
Completed
- Cervical Cancer
- +13 more
- 4-valent HPV Vaccine
- +2 more
-
Yangchun, Guangdong, ChinaYangchun Center For Disease Prevention And Control
Feb 23, 2022
Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Rongan County (9-valent Human Papillomavirus (Types 6, 11, 16,
Recruiting
- Cervical Cancer
- +13 more
- 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha)
- GARDASIL®
-
Rongan County, Guangxi Zhuang Autonomous Region, ChinaRongan County Center for Disease Control and Prevention
Feb 20, 2022